Quanterix Corporation – NASDAQ:QTRX
Founder-led company
Quanterix stock price today
$5
-6.05
-54.79%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in 1 minute
Quanterix stock price monthly change
-23.67%
month
Quanterix stock price quarterly change
-23.67%
quarter
Quanterix stock price yearly change
-60.81%
year
Quanterix key metrics
Market Cap | 404.70M |
Enterprise value | 199.93M |
P/E | -4.53 |
EV/Sales | 1.89 |
EV/EBITDA | -2.32 |
Price/Sales | 4.68 |
Price/Book | 1.37 |
PEG ratio | 0.06 |
EPS | -0.96 |
Revenue | 125.32M |
EBITDA | -46.64M |
Income | -36.30M |
Revenue Q/Q | 13.57% |
Revenue Y/Y | 20.92% |
Profit margin | -91.64% |
Oper. margin | -96.38% |
Gross margin | 44.36% |
EBIT margin | -96.38% |
EBITDA margin | -37.22% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQuanterix stock price history
Quanterix stock forecast
Quanterix financial statements
| Jun 2023 | 30.87M | -6.06M | -19.64% |
|---|---|---|---|
| Sep 2023 | 30.83M | -7.75M | -25.16% |
| Dec 2023 | 31.54M | -12.40M | -39.33% |
| Mar 2024 | 32.06M | -10.07M | -31.41% |
| Mar 2024 | 32.06M | -10.07M | -31.41% |
|---|---|---|---|
| Sep 2025 | 42.76M | -8.93M | -20.89% |
| Oct 2025 | 42.60M | -8.42M | -19.77% |
| Dec 2025 | 45.14M | -8.20M | -18.17% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 429210000 | 73.85M | 17.21% |
|---|---|---|---|
| Sep 2023 | 429042000 | 75.69M | 17.64% |
| Dec 2023 | 425011000 | 78.08M | 18.37% |
| Mar 2024 | 411749000 | 70.31M | 17.08% |
| Jun 2023 | 633K | -648K | 139K |
|---|---|---|---|
| Sep 2023 | -4.04M | -125.98M | 1.8M |
| Dec 2023 | -5.98M | -21.62M | 201K |
| Mar 2024 | -20.16M | -109.19M | 599K |
Quanterix alternative data
| Aug 2023 | 370 |
|---|---|
| Sep 2023 | 3,200 |
| Oct 2023 | 3,200 |
| Nov 2023 | 3,200 |
| Dec 2023 | 370 |
| Jan 2024 | 370 |
| Feb 2024 | 370 |
| Mar 2024 | 441 |
| Apr 2024 | 441 |
| May 2024 | 441 |
| Jun 2024 | 441 |
| Jul 2024 | 441 |
Quanterix other data
89.03%
+2.46%
of QTRX is owned by hedge funds
135
-13
32.04M
+433.9K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 20200 | 0 |
| Jan 2024 | 0 | 1000 |
| Feb 2024 | 0 | 1500 |
| Apr 2024 | 0 | 1000 |
| May 2024 | 0 | 1500 |
| Aug 2024 | 66000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | WALT DAVID R director | Common Stock | 47,000 | $13.29 | $624,630 | ||
Purchase | TOLOUE MASOUD director, officer: President & .. | Common Stock | 19,000 | $10.9 | $207,100 | ||
Sale | OLSON LAURIE J director | Common Stock | 1,500 | $16.98 | $25,470 | ||
Option | OLSON LAURIE J director | Common Stock | 1,000 | $12.86 | $12,860 | ||
Sale | OLSON LAURIE J director | Common Stock | 1,000 | $23.5 | $23,500 | ||
Option | OLSON LAURIE J director | Stock Option (Right to Buy) | 1,000 | $12.86 | $12,860 | ||
Sale | OLSON LAURIE J director | Common Stock | 1,500 | $24.35 | $36,525 | ||
Sale | OLSON LAURIE J director | Common Stock | 1,000 | $26.91 | $26,910 | ||
Option | OLSON LAURIE J director | Common Stock | 1,000 | $12.86 | $12,860 | ||
Option | OLSON LAURIE J director | Stock Option (Right to Buy) | 1,000 | $12.86 | $12,860 |
| Patent |
|---|
Application METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY Filling date: 18 Feb 2022 Issue date: 4 Aug 2022 |
Application METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY Filling date: 1 Feb 2022 Issue date: 21 Jul 2022 |
Application Filling date: 9 Apr 2019 Issue date: 21 Jul 2022 |
Application Filling date: 28 Dec 2020 Issue date: 30 Jun 2022 |
Grant Utility: Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury Filling date: 25 Jul 2019 Issue date: 15 Mar 2022 |
Application Filling date: 11 Aug 2021 Issue date: 17 Feb 2022 |
Application Filling date: 6 Aug 2021 Issue date: 3 Feb 2022 |
Application Filling date: 28 Apr 2021 Issue date: 4 Nov 2021 |
Application METHODS AND SYSTEMS FOR EXTENDING DYNAMIC RANGE IN ASSAYS FOR THE DETECTION OF MOLECULES OR PARTICLES Filling date: 23 Mar 2021 Issue date: 7 Oct 2021 |
Grant Filling date: 14 Mar 2018 Issue date: 7 Sep 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 29 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Quanterix stock today?
One share of Quanterix stock can currently be purchased for approximately $5.
-
When is Quanterix's next earnings date?
Unfortunately, Quanterix's (QTRX) next earnings date is currently unknown.
-
Does Quanterix pay dividends?
No, Quanterix does not pay dividends.
-
How much money does Quanterix make?
Quanterix has a market capitalization of 404.70M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.59% to 122.37M US dollars.
-
What is Quanterix's stock symbol?
Quanterix Corporation is traded on the NASDAQ under the ticker symbol "QTRX".
-
What is Quanterix's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Quanterix?
Shares of Quanterix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Quanterix's key executives?
Quanterix's management team includes the following people:
- Mr. E. Kevin Hrusovsky Chairman & Chief Executive Officer(age: 63, pay: $1,330,000)
- Dr. David R. Walt Ph.D. Co-Founder, Chairman of Scientific Advisory Board & Independent Director(age: 72, pay: $41,000)
-
Is Quanterix founder-led company?
Yes, Quanterix is a company led by its founder Dr. David R. Walt Ph.D..
-
How many employees does Quanterix have?
As Jul 2024, Quanterix employs 441 workers.
-
When Quanterix went public?
Quanterix Corporation is publicly traded company for more then 7 years since IPO on 7 Dec 2017.
-
What is Quanterix's official website?
The official website for Quanterix is quanterix.com.
-
Where are Quanterix's headquarters?
Quanterix is headquartered at Building 1, Billerica, MA.
-
How can i contact Quanterix?
Quanterix's mailing address is Building 1, Billerica, MA and company can be reached via phone at +61 73019400.
Quanterix company profile:
Quanterix Corporation
quanterix.comExchange:
NASDAQ
Full time employees:
441
Industry:
Medical - Devices
Sector:
Healthcare
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Building 1
Billerica, MA 01821
Billerica, MA 01821
CIK: 0001503274
ISIN: US74766Q1013
CUSIP: 74766Q101
